128 related articles for article (PubMed ID: 7199475)
1. Effects of misonidazole on tumor cell radiation sensitivity and potentially lethal damage repair in vivo and in vitro.
Sakamoto K; Aritake S
Eur J Cancer Clin Oncol; 1981 Jul; 17(7):825-30. PubMed ID: 7199475
[No Abstract] [Full Text] [Related]
2. A new approach to the use of misonidazole as a radiosensitizer of hypoxic tumour cells.
Abratt RP
Br J Cancer; 1982 Dec; 46(6):976-9. PubMed ID: 7150492
[No Abstract] [Full Text] [Related]
3. Effect of misonidazole on the radiosensitivity and repair of potentially lethal damage of L5178Y ascites tumor cells.
Nakagawa K; Tsunemoto H; Watanabe I
Eur J Cancer Clin Oncol; 1983 Apr; 19(4):527-32. PubMed ID: 6683187
[TBL] [Abstract][Full Text] [Related]
4. Radiosensitizing effects of misonidazole and SR 2508 on a human melanoma transplanted in nude mice: influence on repair of potentially lethal damage.
Guichard M; Malaise EP
Int J Radiat Oncol Biol Phys; 1982; 8(3-4):465-8. PubMed ID: 6213589
[TBL] [Abstract][Full Text] [Related]
5. Optimizing the interval between administration of misonidazole and irradiation: an in vitro study.
Hall EJ; Astor M
Br J Cancer; 1982 Aug; 46(2):291-3. PubMed ID: 7150477
[No Abstract] [Full Text] [Related]
6. Interaction of misonidazole and WR-2721--II. Modification of tumour radiosensitization.
Rojas A; Stewart FA; Denekamp J
Br J Cancer; 1983 Jan; 47(1):65-72. PubMed ID: 6295429
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of misonidazole-linked cytotoxicity and altered radiation response: role of cellular thiols.
Biaglow JE; Varnes ME; Astor M; Hall EJ
Br J Radiol; 1981 Nov; 54(647):1006-8. PubMed ID: 7306759
[No Abstract] [Full Text] [Related]
8. Studies of the in vivo and in vitro cytotoxicity of the drug RSU-1069.
Hill RP; Gulyas S; Whitmore GF
Br J Cancer; 1986 Jun; 53(6):743-51. PubMed ID: 3755053
[TBL] [Abstract][Full Text] [Related]
9. Effect of hyperthermia and misonidazole on the radiosensitivity of a transplantable murine tumor: influence of factors modifying the fraction of hypoxic cells.
Wondergem J; Haveman J; van der Schueren E; van den Hoeven H; Breur K
Int J Radiat Oncol Biol Phys; 1982 Aug; 8(8):1323-31. PubMed ID: 7141911
[TBL] [Abstract][Full Text] [Related]
10. Combination therapy with misonidazole and mitomycin C: lack of chemosensitization of EMT6 tumor cells in vivo or in vitro.
Rockwell S
Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1631-4. PubMed ID: 6434497
[TBL] [Abstract][Full Text] [Related]
11. Studies on the toxicity and radiosensitizing ability of misonidazole under conditions of prolonged incubation.
Wong TW; Whitmore GF; Gulyas S
Radiat Res; 1978 Sep; 75(3):541-55. PubMed ID: 724984
[No Abstract] [Full Text] [Related]
12. Misonidazole and unconventional radiation in advanced squamous cell carcinoma of the esophagus: a phase II study of the Radiation Therapy Oncology Group.
Ydrach AA; Marcial VA; Parsons J; Concannon J; Asbell SO; George F
Int J Radiat Oncol Biol Phys; 1982; 8(3-4):357-9. PubMed ID: 6809704
[TBL] [Abstract][Full Text] [Related]
13. Bioreductive drugs as post-irradiation sensitizers: comparison of dual function agents with SR 4233 and the mitomycin C analogue EO9.
Adams GE; Stratford IJ; Edwards HS; Bremner JC; Cole S
Int J Radiat Oncol Biol Phys; 1992; 22(4):717-20. PubMed ID: 1544844
[TBL] [Abstract][Full Text] [Related]
14. [Experimental studies on radiosensitization of hypoxic cancer cells].
Omura M
Nihon Sanka Fujinka Gakkai Zasshi; 1983 Nov; 35(11):1972-80. PubMed ID: 6663130
[TBL] [Abstract][Full Text] [Related]
15. Primary tumor control after radiotherapy for carcinoma of the bronchus.
Saunders MI; Bennett MH; Dische S; Anderson PJ
Int J Radiat Oncol Biol Phys; 1984 Apr; 10(4):499-501. PubMed ID: 6373685
[TBL] [Abstract][Full Text] [Related]
16. The radiosensitizing effects of hypoxic cell sensitizer on SCCVII tumors in mice evaluated by highly accurate colony formation assay assisted by microcomputer.
Ono K; Akuta K; Masunaga S; Kinashi Y; Suzuki M
Nihon Igaku Hoshasen Gakkai Zasshi; 1996 Dec; 56(14):1066-70. PubMed ID: 9014470
[No Abstract] [Full Text] [Related]
17. Broad-shouldered survival curves of a human melanoma xenograft. Implications for radiation therapy in the absence and presence of misonidazole.
Rofstad EK; Brustad T
Acta Radiol Oncol; 1981; 20(4):261-5. PubMed ID: 6277155
[TBL] [Abstract][Full Text] [Related]
18. Misonidazole and potentially lethal damage.
Korbelik M; Palcic B; Skov K; Skarsgard L
Int J Radiat Oncol Biol Phys; 1982; 8(3-4):461-4. PubMed ID: 7201990
[TBL] [Abstract][Full Text] [Related]
19. Potentiation of cyclophosphamide cytotoxicity in vivo: a study with misonidazole and fifteen other 1-substituted 2-nitroimidazoles.
Chaplin DJ; Sheldon PW; Ahmed I; Adams GE
Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1647-51. PubMed ID: 6480452
[TBL] [Abstract][Full Text] [Related]
20. Enhancing effect of misonidazole on the response of the RIF-1 tumour to cyclophosphamide.
Law MP; Hirst DG; Brown JM
Br J Cancer; 1981 Aug; 44(2):208-18. PubMed ID: 7272187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
